Eam Global Investors LLC Natera, Inc. Transaction History

Eam Global Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$36.57 - $58.29 $2.73 Million - $4.36 Million	74,771 New	74,771 $4.15 Million
Q4 2018 Feb 13, 2019	SELL	$12.32 - $24.38 $743,820 - $1.47 Million	-60,375 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$18.82 - $28.96 $218,123 - $335,646	-11,590 Reduced 16.11%	60,375 $1.45 Million
Q2 2018 Aug 03, 2018	BUY	$8.79 - $19.98 $632,572 - $1.44 Million	71,965 New	71,965 $1.35 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.